Crinetics Pharmaceuticals, Inc. (CRNX) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$132.46M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$140.38M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$142.59M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$129.11M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2023-12-31 to 2025-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$132.46M | (m) | $25.12M | (m) | $521.00K* | -$94.19M* | (m) | $99.85M | (m) | (m) |
|---|
| 2026-03-31 | Reported | (m) | -$140.38M | (m) | $10.73M | (m) | $820.00K | -$124.70M | (m) | $100.08M | (m) | (m) |
|---|
| 2025-09-30 | Reported | (m) | -$142.59M | (m) | $143.00K | (m) | $863.00K* | -$110.72M* | (m) | $90.46M | (m) | (m) |
|---|
| 2025-06-30 | Reported | (m) | -$129.11M | (m) | $1.03M | (m) | $3.20M* | -$85.85M* | (m) | $80.30M | $49.84M | (m) |
|---|
| 2025-03-31 | Reported | (m) | -$111.41M | (m) | $361.00K | (m) | $1.24M | -$88.45M | (m) | $76.24M | $35.53M | (m) |
|---|
| 2024-09-30 | Reported | (m) | -$87.80M | (m) | $0.00 | (m) | $528.00K* | -$62.82M* | (m) | $61.91M | (m) | (m) |
|---|
| 2024-06-30 | Reported | (m) | -$82.78M | (m) | $399.00K | (m) | $955.00K* | -$47.64M* | (m) | $58.34M | $24.84M | (m) |
|---|
| 2024-03-31 | Reported | (m) | -$73.53M | (m) | $640.00K | (m) | $1.33M | -$52.86M | (m) | $53.34M | $20.83M | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$58.98M | (m) | $346.00K | (m) | $3.50M* | -$41.34M* | (m) | $43.84M | (m) | (m) |
|---|
| 2023-06-30 | Reported | (m) | -$52.99M | (m) | $988.00K | (m) | $237.00K* | -$45.73M* | (m) | $40.64M | (m) | (m) |
|---|
| 2023-03-31 | Reported | (m) | -$47.98M | (m) | $2.68M | (m) | $16.00K | -$40.72M | (m) | $38.47M | (m) | (m) |
|---|
| 2022-09-30 | Reported | (m) | -$43.45M | (m) | $458.00K | (m) | $682.00K* | -$38.48M* | (m) | $31.99M | (m) | (m) |
|---|
| 2022-06-30 | Reported | (m) | -$43.05M | (m) | $439.00K | (m) | $613.00K* | -$27.98M* | (m) | $32.99M | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$33.83M | (m) | $3.13M | (m) | $87.00K | -$13.54M | (m) | $28.25M | (m) | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$27.81M | (m) | $0.00 | (m) | $140.00K* | -$25.67M* | (m) | $21.58M | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$26.09M | (m) | (m) | (m) | $162.00K* | -$19.95M* | (m) | $20.49M | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$22.92M | (m) | $0.00 | (m) | $116.00K | -$20.07M | (m) | $17.58M | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$18.45M | (m) | $0.00* | (m) | $97.00K* | -$18.00M* | (m) | $13.70M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$16.93M | (m) | $0.00* | (m) | $12.00K* | -$15.86M* | (m) | $12.61M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$17.78M | (m) | $71.00K | (m) | $60.00K | -$12.23M | (m) | $13.86M | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$15.23M | (m) | $505.00K | (m) | $0.00* | -$13.61M* | (m) | $11.82M | (m) | (m) |
|---|
| 2019-06-30 | Reported | (m) | -$13.35M | (m) | $0.00* | (m) | $56.00K* | -$12.57M* | (m) | $10.29M | (m) | (m) |
|---|
| 2019-03-31 | Reported | (m) | -$10.04M | (m) | $367.00K | (m) | $408.00K | -$6.76M | (m) | $7.25M | (m) | (m) |
|---|
| 2018-09-30 | Reported | (m) | -$8.07M | (m) | $548.00K | (m) | $251.00K* | -$5.69M* | (m) | $6.89M | (m) | (m) |
|---|
| 2018-06-30 | Reported | (m) | -$5.68M | (m) | $657.00K | (m) | $469.00K* | -$4.35M* | (m) | $5.22M | (m) | (m) |
|---|
| 2018-03-31 | Reported | (m) | -$5.53M | (m) | $442.00K | (m) | $57.00K | -$3.41M | (m) | $4.72M | (m) | (m) |
|---|
| 2017-09-30 | Reported | (m) | -$2.37M | (m) | $640.00K | (m) | $18.00K* | -$2.44M* | (m) | $2.52M | (m) | (m) |
|---|
| 2017-06-30 | Reported | (m) | -$1.64M | (m) | $832.00K | (m) | (m) | (m) | (m) | $2.08M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$512.87M | (m) | (m) | (m) | -6664.10% | $5.76M | -$377.92M | (m) | $332.06M | $191.33M | $180.00K |
|---|
| 2024-12-31 | Reported | -$336.05M | (m) | (m) | (m) | -32343.98% | $3.84M | -$230.19M | (m) | $240.16M | $99.74M | $0.00 |
|---|
| 2023-12-31 | Reported | -$221.51M | (m) | (m) | (m) | -5519.76% | $4.69M | -$168.60M | (m) | $168.53M | $58.09M | $0.00 |
|---|
| 2022-12-31 | Reported | (m) | -$167.88M | (m) | $0.00 | (m) | $1.66M | -$115.20M | (m) | $130.22M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | (m) | -$107.70M | (m) | $0.00 | (m) | $436.00K | -$88.59M | (m) | $84.25M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | (m) | -$74.95M | (m) | $71.00K | (m) | $186.00K | -$62.03M | (m) | $57.00M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | (m) | -$53.83M | (m) | $1.19M | (m) | $492.00K | -$46.38M | (m) | $41.51M | (m) | $0.00 |
|---|
| 2018-12-31 | Reported | (m) | -$28.71M | (m) | $2.43M | (m) | $1.06M | -$19.46M | (m) | $24.48M | (m) | $0.00 |
|---|
| 2017-12-31 | Reported | (m) | -$9.13M | (m) | $2.04M | (m) | $304.00K | -$9.48M | (m) | $9.23M | (m) | $0.00 |
|---|
| 2016-12-31 | Reported | (m) | -$6.04M | (m) | $589.00K | (m) | $190.00K | -$5.47M | (m) | $5.10M | (m) | $0.00 |
|---|